JAMES P. KEESE for TEVA PHARMACEUTICALS USA

Copyright/Patent/Trademark CPT

H.R. 1432 - Preserve Access to Affordable Generics Act, S. 316 - Preserve Access to Affordable Generics Act,H.R. 1908 - Patent Reform Act of 2007, S. 1145 - Patent Reform Act of 2007, H.R. 1902 - Protecting Consumer Access to Generic Drugs Act

Foreign entity interest: Teva Pharmaceutical Industries, Ltd., as an indirect parent of Teva Pharmaceuticals USA, has an interest in the issues listed above

Contacted: Health & Human Services, Dept of (HHS); SENATE; Federal Trade Commission (FTC); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO)

Bills named: S. 1145 (110th), H.R. 1432 (110th), S. 316 (110th), H.R. 1908 (110th), H.R. 1902 (110th)

Pharmacy PHA

S. 623/Access to Life-Saving Medicine Act, S. 438/Fair Prescription Drug Competition Act, H.R. 806/Fair Prescription Drug Competition Act, H.R. 1956/Patient Protection and Innovative Biologic Medicines Act of 2007, H.R. 5629, H.R. 1038/Access to Life-Saving Medicine Act, S. 1505/Affordable Biologics for Consumers Act, S. 1695/Biologics Act of 2007, HR 3610

Foreign entity interest: Teva Pharmaceutical Industries, Ltd., as an indirect parent of Teva Pharmaceuticals USA, has an interest in the issues listed above

Contacted: U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); SENATE; Federal Trade Commission (FTC); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES

Bills named: H.R. 5629 (110th), H.R. 1038 (110th), S. 1505 (110th), H.R. 806 (110th), S. 623 (110th), S. 438 (110th), S. 1695 (110th), H.R. 1956 (110th), H.R. 3610 (110th)

Trade (domestic/foreign) TRD

Matters relating to Israeli data exclusivity, matters relating to pharmaceutical provisions in free trade agreements.

Foreign entity interest: Teva Pharmaceutical Industries, Ltd., as an indirect parent of Teva Pharmaceuticals USA, has an interest in the issues listed above

Contacted: Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); SENATE; U.S. Trade Representative (USTR); Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS); Federal Trade Commission (FTC); HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

S. 1951 - The Fair Medicaid Drug Payment Act of 2007 H.R. 3700 - The Fair Medicaid Drug Payment Act of 2007 H.R. 3140 - Saving Our Community Pharmacies Act of 2007

Foreign entity interest: Teva Pharmaceutical Industries, Ltd., as an indirect parent of Teva Pharmaceuticals USA, has an interest in the issues listed above

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Federal Trade Commission (FTC); Patent & Trademark Office (PTO); U.S. Trade Representative (USTR)

Bills named: S. 1951 (110th), H.R. 3140 (110th), H.R. 3700 (110th)

Budget/Appropriations BUD

President Bush FY 2008 Budget Request - $15.7 million dollars Generic Drug User Fees. Matters relating to FDA Office of Generic Drugs funding. Agriculture Appropriations.

Foreign entity interest: Teva Pharmaceutical Industries, Ltd., as an indirect parent of Teva Pharmaceuticals USA, has an interest in the issues listed above

Contacted: Patent & Trademark Office (PTO); Centers For Medicare and Medicaid Services (CMS); Federal Trade Commission (FTC); Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE